The present invention features calcilytic compounds. “Calcilytic compounds” refer to compounds able to inhibit calcium receptor activity. Also described are the use of calcilytic compounds to inhibit calcium receptor activity and/or achieve a beneficial effect in a patient; and techniques which can be used to obtain additional calcilytic compounds.
本发明涉及
钙解离化合物。 “
钙解离化合物”是指能够抑制
钙受体活性的化合物。同时,本发明还描述了使用
钙解离化合物来抑制
钙受体活性和/或在患者中获得有益效果的方法;以及可用于获得其他
钙解离化合物的技术。